PMC:7291971 / 18364-19022 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T414","span":{"begin":54,"end":57},"obj":"NCBITaxon:11886"},{"id":"T415","span":{"begin":73,"end":80},"obj":"NCBITaxon:10239"}],"text":"Compounds Percentage of inhibition at 50 μM (%)a\nSARS-CoV nsp14 Vaccinia virusD1-D12 hRNMT\nSinefungin 98.3 ± 0.2 99.8 ± 0.1 99.8 ± 0.2\n1 31.0 ± 6.8 20.3 ± 0.8 35.2 ± 4.9\n2 72.0 ± 1.2 85.8 ± 2.5 77.4 ± 1.2\n3 30.6 ± 9.3 32.1 ± 2.4 33.2 ± 4.3\n4 13.1 ± 13.3 53.2 ± 2.6 12.2 ± 2.1\n5 n.i n.i 27.5 ± 6.6\n6 38.4 ± 11.7 11.6 ± 7.1 23.1 ± 9.7\n7 n.i 69.2 ± 1.9 32.8 ± 16.1\n8 43.0 ± 4.0 n.i n.i\n9 88.6 ± 1.3 49.8 ± 3.2 66.0 ± 6.1\n10 96.6 ± 0.9 4.6 ± 0.3 31.8 ± 3.3\n11 47.6 ± 2.8 5.3 ± 4.3 44.2 ± 8.5\n12 94.6 ± 1.1 10.1 ± 5.5 23.3 ± 3.6\n13 97.2 ± 2.7 2.8 ± 0.8 33.9 ± 3.3\n14 96.2 ± 1.5 19.7 ± 3.8 20.2 ± 9.4\n15 94.0 ± 1.1 4.3 ± 3.9 n.i\n16 75.9 ± 2.5 4.5 ± 15.1 14.7 ± 1.3"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T43","span":{"begin":49,"end":57},"obj":"Disease"},{"id":"T44","span":{"begin":64,"end":72},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0002595"}],"text":"Compounds Percentage of inhibition at 50 μM (%)a\nSARS-CoV nsp14 Vaccinia virusD1-D12 hRNMT\nSinefungin 98.3 ± 0.2 99.8 ± 0.1 99.8 ± 0.2\n1 31.0 ± 6.8 20.3 ± 0.8 35.2 ± 4.9\n2 72.0 ± 1.2 85.8 ± 2.5 77.4 ± 1.2\n3 30.6 ± 9.3 32.1 ± 2.4 33.2 ± 4.3\n4 13.1 ± 13.3 53.2 ± 2.6 12.2 ± 2.1\n5 n.i n.i 27.5 ± 6.6\n6 38.4 ± 11.7 11.6 ± 7.1 23.1 ± 9.7\n7 n.i 69.2 ± 1.9 32.8 ± 16.1\n8 43.0 ± 4.0 n.i n.i\n9 88.6 ± 1.3 49.8 ± 3.2 66.0 ± 6.1\n10 96.6 ± 0.9 4.6 ± 0.3 31.8 ± 3.3\n11 47.6 ± 2.8 5.3 ± 4.3 44.2 ± 8.5\n12 94.6 ± 1.1 10.1 ± 5.5 23.3 ± 3.6\n13 97.2 ± 2.7 2.8 ± 0.8 33.9 ± 3.3\n14 96.2 ± 1.5 19.7 ± 3.8 20.2 ± 9.4\n15 94.0 ± 1.1 4.3 ± 3.9 n.i\n16 75.9 ± 2.5 4.5 ± 15.1 14.7 ± 1.3"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T154","span":{"begin":47,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T155","span":{"begin":453,"end":455},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"Compounds Percentage of inhibition at 50 μM (%)a\nSARS-CoV nsp14 Vaccinia virusD1-D12 hRNMT\nSinefungin 98.3 ± 0.2 99.8 ± 0.1 99.8 ± 0.2\n1 31.0 ± 6.8 20.3 ± 0.8 35.2 ± 4.9\n2 72.0 ± 1.2 85.8 ± 2.5 77.4 ± 1.2\n3 30.6 ± 9.3 32.1 ± 2.4 33.2 ± 4.3\n4 13.1 ± 13.3 53.2 ± 2.6 12.2 ± 2.1\n5 n.i n.i 27.5 ± 6.6\n6 38.4 ± 11.7 11.6 ± 7.1 23.1 ± 9.7\n7 n.i 69.2 ± 1.9 32.8 ± 16.1\n8 43.0 ± 4.0 n.i n.i\n9 88.6 ± 1.3 49.8 ± 3.2 66.0 ± 6.1\n10 96.6 ± 0.9 4.6 ± 0.3 31.8 ± 3.3\n11 47.6 ± 2.8 5.3 ± 4.3 44.2 ± 8.5\n12 94.6 ± 1.1 10.1 ± 5.5 23.3 ± 3.6\n13 97.2 ± 2.7 2.8 ± 0.8 33.9 ± 3.3\n14 96.2 ± 1.5 19.7 ± 3.8 20.2 ± 9.4\n15 94.0 ± 1.1 4.3 ± 3.9 n.i\n16 75.9 ± 2.5 4.5 ± 15.1 14.7 ± 1.3"}

{"project":"LitCovid-sentences","denotations":[{"id":"T114","span":{"begin":0,"end":48},"obj":"Sentence"},{"id":"T115","span":{"begin":49,"end":90},"obj":"Sentence"},{"id":"T116","span":{"begin":91,"end":134},"obj":"Sentence"},{"id":"T117","span":{"begin":135,"end":169},"obj":"Sentence"},{"id":"T118","span":{"begin":170,"end":204},"obj":"Sentence"},{"id":"T119","span":{"begin":205,"end":239},"obj":"Sentence"},{"id":"T120","span":{"begin":240,"end":275},"obj":"Sentence"},{"id":"T121","span":{"begin":276,"end":296},"obj":"Sentence"},{"id":"T122","span":{"begin":297,"end":332},"obj":"Sentence"},{"id":"T123","span":{"begin":333,"end":361},"obj":"Sentence"},{"id":"T124","span":{"begin":362,"end":382},"obj":"Sentence"},{"id":"T125","span":{"begin":383,"end":417},"obj":"Sentence"},{"id":"T126","span":{"begin":418,"end":452},"obj":"Sentence"},{"id":"T127","span":{"begin":453,"end":487},"obj":"Sentence"},{"id":"T128","span":{"begin":488,"end":523},"obj":"Sentence"},{"id":"T129","span":{"begin":524,"end":558},"obj":"Sentence"},{"id":"T130","span":{"begin":559,"end":594},"obj":"Sentence"},{"id":"T131","span":{"begin":595,"end":622},"obj":"Sentence"},{"id":"T132","span":{"begin":623,"end":658},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Compounds Percentage of inhibition at 50 μM (%)a\nSARS-CoV nsp14 Vaccinia virusD1-D12 hRNMT\nSinefungin 98.3 ± 0.2 99.8 ± 0.1 99.8 ± 0.2\n1 31.0 ± 6.8 20.3 ± 0.8 35.2 ± 4.9\n2 72.0 ± 1.2 85.8 ± 2.5 77.4 ± 1.2\n3 30.6 ± 9.3 32.1 ± 2.4 33.2 ± 4.3\n4 13.1 ± 13.3 53.2 ± 2.6 12.2 ± 2.1\n5 n.i n.i 27.5 ± 6.6\n6 38.4 ± 11.7 11.6 ± 7.1 23.1 ± 9.7\n7 n.i 69.2 ± 1.9 32.8 ± 16.1\n8 43.0 ± 4.0 n.i n.i\n9 88.6 ± 1.3 49.8 ± 3.2 66.0 ± 6.1\n10 96.6 ± 0.9 4.6 ± 0.3 31.8 ± 3.3\n11 47.6 ± 2.8 5.3 ± 4.3 44.2 ± 8.5\n12 94.6 ± 1.1 10.1 ± 5.5 23.3 ± 3.6\n13 97.2 ± 2.7 2.8 ± 0.8 33.9 ± 3.3\n14 96.2 ± 1.5 19.7 ± 3.8 20.2 ± 9.4\n15 94.0 ± 1.1 4.3 ± 3.9 n.i\n16 75.9 ± 2.5 4.5 ± 15.1 14.7 ± 1.3"}